Search Results - "Dorman, S.E."

Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis by Xie, Yingda L, Chakravorty, Soumitesh, Armstrong, Derek T, Hall, Sandra L, Via, Laura E, Song, Taeksun, Yuan, Xing, Mo, Xiaoying, Zhu, Hong, Xu, Peng, Gao, Qian, Lee, Myungsun, Lee, Jongseok, Smith, Laura E, Chen, Ray Y, Joh, Joon Sung, Cho, YoungSoo, Liu, Xin, Ruan, Xianglin, Liang, Lili, Dharan, Nila, Cho, Sang-Nae, Barry, Clifton E, Ellner, Jerrold J, Dorman, Susan E, Alland, David

“…Increasing drug resistance in Mycobacterium tuberculosis complicates the management of tuberculosis. Development of a point-of-care test to determine drug…”
Get full text

Facilitators and barriers to adolescent participation in a TB clinical trial by Mangan, J.M., Hedges, K.N.C., Salerno, M.M., Tatum, K., Bouwkamp, B., Frick, M.W., McKenna, L., Muzanyi, G., Engle, M., Coetzee, J., Yvetot, J., Elskamp, M., Lamunu, D., Tizora, M.E. Theunissen, Namutamba, D., Chaisson, R.E., Swindells, S., Nahid, P., Dorman, S.E., Kurbatova, E.

“…BACKGROUND The inclusion of adolescents in TB drug trials is essential for the development of safe, child-friendly regimens for the prevention and treatment of…”
Get full text

Some comments on the Arcan mixed-mode (I/II) test specimen by Greer, J.M., Galyon Dorman, S.E., Hammond, M.J.

“…Although the Arcan specimen has been used frequently for mixed-mode crack growth testing using single-axis servohydraulic test equipment, the specimen and its…”
Get full text

One step further: improving paediatric TB diagnosis through user-centred research approaches by Basile, F.W., Bijker, E.M., Sekadde, M., Dorman, S.E., Ellner, J.J., Engel, N., Ruhwald, M., Song, R.

Get full text

Fulminant babesiosis treated with clindamycin, quinine,and whole-blood exchange transfusion by Dorman, S.E., Cannon, M.E., Telford III, S.R., Frank, K.M., Churchill, W.H.

“…BACKGROUND: Babesiosis is an increasingly recognized parasitic infection with manifestations that range from a subclinical or mild flu‐like illness to…”
Get full text

561del4 Defines a Novel Small Deletion Hotspot in the Interferon-γ Receptor 1 Chain by Rosenzweig, S., Dorman, S.E., Roesler, J., Palacios, J., Zelazko, M., Holland, S.M.

“…Patients with a dominant small deletion (818del4, hotspot) in the interferon-γ receptor 1 (IFNGR1) gene (6q23–q24) and increased susceptibility to…”
Get full text